Compare TUYA & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TUYA | BLFS |
|---|---|---|
| Founded | 2014 | 1987 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 2021 | 2013 |
| Metric | TUYA | BLFS |
|---|---|---|
| Price | $2.30 | $22.65 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $3.49 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 990.5K | 325.7K |
| Earning Date | 01-01-0001 | 04-14-2026 |
| Dividend Yield | ★ 4.66% | N/A |
| EPS Growth | N/A | ★ 71.05 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $82,254,000.00 |
| Revenue This Year | $8.84 | $18.45 |
| Revenue Next Year | $12.17 | $16.27 |
| P/E Ratio | $27.45 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.87 | $19.15 |
| 52 Week High | $4.17 | $29.57 |
| Indicator | TUYA | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 65.79 | 48.84 |
| Support Level | $2.24 | $20.34 |
| Resistance Level | $2.45 | $26.77 |
| Average True Range (ATR) | 0.10 | 0.96 |
| MACD | 0.03 | 0.16 |
| Stochastic Oscillator | 98.81 | 73.62 |
Tuya Inc is an AI cloud platform service provider dedicated to bringing AI into everyday life. The group leverages its TuyaOpen open-source framework and universal AI Agent engines, including the AI Agent development platform, to integrate multimodal AI capabilities and reduce barriers to AI development. It drives the adoption of AI-powered lifestyles and speeds up the integration of AI with the physical world. It offers innovative physical AI solutions for smart devices, commercial use, and industry developers using cloud computing and spatial intelligence. It also provides a complete, open, and neutral global AIoT ecosystem. It builds a developer community that collaborates to create smart solutions grounded in sustainability, security, efficiency, agility, and openness.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.